TENAX THERAPEUTICS, INC. Payments of Debt Issuance Costs
TENAX THERAPEUTICS, INC. (TENX) reported Payments of Debt Issuance Costs of $340.64 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2024-08-13
- TENAX THERAPEUTICS, INC. payments of debt issuance costs for the quarter ending 2024-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. payments of debt issuance costs for the quarter ending 2024-03-31 was $340.64K, a 20.52% increase year-over-year.
- TENAX THERAPEUTICS, INC. payments of debt issuance costs for the quarter ending 2023-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. payments of debt issuance costs for the quarter ending 2023-03-31 was $282.65K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month |
|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $340.64K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $340.64K 10-Q · filed 2024-05-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $282.65K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $282.65K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |